Barclays Morning Research Summary: Commodities, Comcast And Healthcare In Focus


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Barclays has downgraded Plains GP Holdings LP (NYSE: PAGP), while revising the price targets of Comcast Corporation (NASDAQ: CMCSA), Johnson & Johnson (NYSE: JNJ), Juno Therapeutics Inc (NASDAQ: JUNO) and Plains All American Pipeline, L.P. (NYSE: PAA).

The brokerage has downgraded Plains GP to Equal Weight from Overweight on dividend concerns. However, analyst Christine Cho raised the price target to $11 from $8.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Meanwhile, Barclays has raised the price target of Comcast to $69 (prior: $65), Johnson & Johnson to $125 (prior: $120) and Plains All American to $30 (prior: $23). The brokerage has an Overweight rating on Comcast and Johnson & Johnson, while remaining Equal Weight on Plains All American.

In addition, Barclays slashed the price target of Juno Therapeutics by 27 percent to $35 after it announced the death of two cancer patients in a mid-stage study of JCAR015. That said, the brokerage remains Equal Weighted on the stock.

"[W]e are lowering our PT on JUNO to $35 (from $48), reflecting a delay in approval on the ROCKET trial, lowered probability of success for this trial, and an higher discount rate - pending clarity on the potential impact on other programs," analyst Jonathan Eckard wrote in a note.

At Time Of Writing...

  • Plains GP shares were flat at $9.90.
  • Plains All American rose 1.30 percent to $27.18.
  • Comcast gained 0.47 percent to $66.57.
  • Johnson & Johnson were up 0.02 percent to $122.52.
  • Juno Therapeutics plunged 32.08 percent to $27.73.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorBiotechDowngradesHealth CarePrice TargetCommoditiesReiterationMarketsAnalyst RatingsGeneralBarclaysJonathan Eckard